NDC properties for "0.8 ML Amjevita 50 MG/ML Prefilled Syringe" (RxCUI 2627725)
About this data
The tables show NDC propoerties for 0.8 ML Amjevita 50 MG/ML Prefilled Syringe with the RxCUI 2627725
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 0.8 ML Amjevita 50 MG/ML Prefilled Syringe (RxCUI 2627725)
| BLA | BLA761024 |
|---|---|
| MMSL_CODE | BD32553 |
| RxCUI | 2627725 |
| SPL_SET_ID | 885b328c-8038-4d08-b047-30ecd5337a7b |
| SPL_SET_ID | 9c44bd5b-4464-40a4-8933-8680950f00f2 |
| Prescribable Synonym | AMJEVITA 40 MG in 0.8 ML Prefilled Syringe |
| RXNAV_STR | 0.8 ML Amjevita 50 MG/ML Prefilled Syringe |
| RxNorm Name | 0.8 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] |
| RxNorm Synonym | 0.8 ML Amjevita 50 MG/ML Prefilled Syringe |
| RxNorm Synonym | Amjevita 40 MG per 0.8 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2627725) |
NDC Properties
NDC Item 50090641100
| NDC 9 | 50090-6411 |
|---|---|
| NDC 10 | 50090-6411-0 |
| NDC Item | 50090641100 |
| Packaging | 1 SYRINGE in 1 CARTON (50090-6411-0) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 705859 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-6411 |
NDC Item 55513041001
| NDC 9 | 55513-410 |
|---|---|
| NDC 10 | 55513-410-01 |
| NDC Item | 55513041001 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-410-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 770230 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-410 |
NDC Item 55513041002
| NDC 9 | 55513-410 |
|---|---|
| NDC 10 | 55513-410-02 |
| NDC Item | 55513041002 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-410-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 770230 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-410 |
NDC Item 50090641100
| NDC 9 | 50090-6411 |
|---|---|
| NDC 10 | 50090-6411-0 |
| NDC Item | 50090641100 |
| Packaging | 1 SYRINGE in 1 CARTON (50090-6411-0) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 705859 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-6411 |
NDC Item 55513041001
| NDC 9 | 55513-410 |
|---|---|
| NDC 10 | 55513-410-01 |
| NDC Item | 55513041001 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-410-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 770230 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-410 |
NDC Item 55513041002
| NDC 9 | 55513-410 |
|---|---|
| NDC 10 | 55513-410-02 |
| NDC Item | 55513041002 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-410-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 770230 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-410 |
NDC Item 50090641100
| NDC 9 | 50090-6411 |
|---|---|
| NDC 10 | 50090-6411-0 |
| NDC Item | 50090641100 |
| Packaging | 1 SYRINGE in 1 CARTON (50090-6411-0) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 705859 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-6411 |
NDC Item 55513041001
| NDC 9 | 55513-410 |
|---|---|
| NDC 10 | 55513-410-01 |
| NDC Item | 55513041001 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-410-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 770230 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-410 |
NDC Item 55513041002
| NDC 9 | 55513-410 |
|---|---|
| NDC 10 | 55513-410-02 |
| NDC Item | 55513041002 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-410-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 770230 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-410 |